Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today about a recent patent reform agreement reached by Members of Congress:

“We applaud Senators Leahy, Sessions, Hatch and others for their work in reaching an agreement on patent reform that balances the interests of a very diverse group of stakeholders across American business sectors. This agreement represents another step forward toward our shared goal of legislation that protects the integrity of the U.S. patent system, which provides American businesses with incentives that drive innovation and create jobs across the country. The tireless work by these and other Members of Congress and their staff bears witness to their appreciation of the importance of intellectual property protection to the U.S. economy and to the jobs that it provides. A strong patent system is crucial to our economic competitiveness, especially in these economically trying times.”

Leave a Reply

Your email address will not be published. Required fields are marked *